Literature DB >> 19116245

Transcriptional regulation of the human growth hormone receptor (hGHR) gene V2 promoter by transcriptional activators and repressor.

Yuhong Wei1, Svetlana Puzhko, Martin Wabitsch, Cynthia Gates Goodyer.   

Abstract

The V2 transcript is the major ubiquitously expressed human GH receptor (hGHR) mRNA in all tissues examined to date. In a previous investigation, we defined the V2 promoter as TATA-less and exhibiting many characteristics of a housekeeping gene promoter. We also demonstrated that its basal activity is determined by several different cis-regulatory regions within both the promoter and the V2 exon. In the present study, we used luciferase-reporter, site-directed mutagenesis, gel shift, chromatin immunoprecipitation, and quantitative RT-PCR assays to investigate the ability of certain transcription factors to regulate hGHR V2 transcription through these regions in mammalian cells, including human adipocytes. Ets1 was found to transactivate the V2 proximal promoter through specific Ets sites. Two CCAAT/enhancer-binding protein (C/EBP) family members [C/EBP-homologous protein (CHOP) and C/EBPbeta] enhanced V2 transcription via different pathways: indirectly, by association with a V2 exon region (CHOP), and directly, using a V2 proximal promoter noncanonical binding site (C/EBPbeta). The Notch signaling mediator, Hes1, potently suppressed V2 promoter activity through interaction with two Hes sites within the V2 exon. We propose that these transcriptional factors regulate hGHR V2 expression by acting as downstream nuclear effectors, linking specific signaling cascades (e.g. MAPK and Notch) triggered by different growth factor-, development-, and nutrition- as well as stress-related stimuli. Our data also suggest that these factors are likely to be important in the differentiation-induced increase in V2 mRNA expression in adipocytes, with Ets1 and CHOP functioning at the preadipocyte stage to prepare the cells for differentiation and increasing C/EBPs and decreasing Hes1 levels contributing during adipocyte maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116245      PMCID: PMC5428159          DOI: 10.1210/me.2008-0190

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  99 in total

Review 1.  Amino acid regulation of gene expression.

Authors:  C Jousse; A Bruhat; P Fafournoux
Journal:  Curr Opin Clin Nutr Metab Care       Date:  1999-07       Impact factor: 4.294

Review 2.  McBindall--a better name for CCAAT/enhancer binding proteins?

Authors:  S L McKnight
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

Review 3.  The oncogenic potential of growth hormone.

Authors:  Jo K Perry; B Starling Emerald; Hichem C Mertani; Peter E Lobie
Journal:  Growth Horm IGF Res       Date:  2006-11-13       Impact factor: 2.372

4.  Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif.

Authors:  J A Nye; J M Petersen; C V Gunther; M D Jonsen; B J Graves
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

5.  The kidney-expressed winged helix transcription factor FREAC-4 is regulated by Ets-1. A possible role in kidney development.

Authors:  A Cederberg; M Hulander; P Carlsson; S Enerbäck
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

6.  Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery.

Authors:  M Hermansson; R B Wickelgren; F Hammarqvist; R Bjarnason; I Wennström; J Wernerman; B Carlsson; L M Carlsson
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

Review 7.  Effects of growth hormone on glucose and fat metabolism in human subjects.

Authors:  Jens O L Jørgensen; Louise Møller; Morten Krag; Nils Billestrup; Jens S Christiansen
Journal:  Endocrinol Metab Clin North Am       Date:  2007-03       Impact factor: 4.741

8.  Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis.

Authors:  Qi-Qun Tang; Mads Grønborg; Haiyan Huang; Jae-Woo Kim; Tamara C Otto; Akhilesh Pandey; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-28       Impact factor: 11.205

9.  Clustering of DNA sequences in human promoters.

Authors:  Peter C FitzGerald; Andrey Shlyakhtenko; Alain A Mir; Charles Vinson
Journal:  Genome Res       Date:  2004-07-15       Impact factor: 9.043

10.  Signalling downstream of activated mammalian Notch.

Authors:  S Jarriault; C Brou; F Logeat; E H Schroeter; R Kopan; A Israel
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

View more
  5 in total

Review 1.  The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions.

Authors:  M Filopanti; C Giavoli; S Grottoli; A Bianchi; L De Marinis; E Ghigo; A Spada
Journal:  J Endocrinol Invest       Date:  2011-12       Impact factor: 4.256

2.  CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland.

Authors:  Heather L LaMarca; Adriana P Visbal; Chad J Creighton; Hao Liu; Yiqun Zhang; Fariba Behbod; Jeffrey M Rosen
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

3.  Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism.

Authors:  Silvia Zecchini; Matteo Giovarelli; Cristiana Perrotta; Federica Morisi; Thierry Touvier; Ilaria Di Renzo; Claudia Moscheni; Maria Teresa Bassi; Davide Cervia; Marco Sandri; Emilio Clementi; Clara De Palma
Journal:  Autophagy       Date:  2018-09-10       Impact factor: 16.016

4.  Structure and activity of the human growth hormone receptor (hGHR) gene V2 promoter.

Authors:  Yuhong Wei; Svetlana Puzhko; Martin Wabitsch; Cynthia Gates Goodyer
Journal:  Mol Endocrinol       Date:  2008-12-30

5.  Regulation of human growth hormone receptor expression by microRNAs.

Authors:  Samar Elzein; Cynthia Gates Goodyer
Journal:  Mol Endocrinol       Date:  2014-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.